In progress

Treatment of Breakthrough and Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients: 2022 Clinical Practice Guideline Update


Scope: Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric patients with cancer.
Methods: An international and multidisciplinary panel used the GRADE approach to develop recommendations based on the results of systematic reviews of the literature.

Related Guidance


View our guidance library

Explore guidance for providing optimal supportive care to children receiving cancer treatments or undergoing bone marrow transplant.

Stay connected

Sign up to receive the iPOG Network quarterly newsletter!